Raab & Moskowitz Asset Management’s Cascadian Therapeutics, Inc. CASC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2015
Q1
Sell
-250
Closed -$3K 440
2014
Q4
$3K Buy
+250
New +$3K ﹤0.01% 432